GLP-1 Receptor Agonists: A New Class of Diabetes Drugs
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of anti-diabetic medications used primarily for the treatment of type 2 diabetes. They mimic the effects of …
Empowering Industries, Enlightening Minds
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of anti-diabetic medications used primarily for the treatment of type 2 diabetes. They mimic the effects of …
The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 12.3 billion in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 14319.85 Mn in 2023 and is expected to exhibit a CAGR of 17.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.